001     181748
005     20240229145656.0
024 7 _ |a 10.1136/jitc-2022-005551
|2 doi
024 7 _ |a altmetric:136054454
|2 altmetric
024 7 _ |a pmid:36113897
|2 pmid
037 _ _ |a DKFZ-2022-02208
082 _ _ |a 610
100 1 _ |a Arkhypov, Ihor
|0 P:(DE-HGF)0
|b 0
|e First author
245 _ _ |a HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling
260 _ _ |a London
|c 2022
|b BioMed Central
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1685446037_28112
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:A370#LA:A370#
536 _ _ |a 311 - Zellbiologie und Tumorbiologie (POF4-311)
|0 G:(DE-HGF)POF4-311
|c POF4-311
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: inrepo02.dkfz.de
700 1 _ |a Ozbay Kurt, Feyza Gul
|0 P:(DE-He78)1784bfc87359b14c283e6b02cabca28d
|b 1
|e First author
|u dkfz
700 1 _ |a Bitsch, Rebekka
|0 P:(DE-He78)d56d42ddfa25c8d79cba10aed608b0df
|b 2
|u dkfz
700 1 _ |a Novak, Daniel
|0 P:(DE-He78)5f0b1c9863f44d0695555ee3c22b9758
|b 3
|u dkfz
700 1 _ |a Petrova, Vera
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Lasser, Samantha
|0 P:(DE-He78)0a2b5a217e49dccee55281ec2fb99f38
|b 5
|u dkfz
700 1 _ |a Hielscher, Thomas
|0 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
|b 6
|u dkfz
700 1 _ |a Groth, Christopher
|0 P:(DE-He78)b3119317bcde901d53a7f3cea31994b5
|b 7
700 1 _ |a Lepper, Alisa
|0 P:(DE-He78)8016386dca5752ba923e058df5966274
|b 8
|u dkfz
700 1 _ |a Hu, Xiaoying
|0 P:(DE-He78)9f73dd6f3a8b9ba22a653f5d0257bd6f
|b 9
700 1 _ |a Li, Wei
|0 P:(DE-He78)70ce269695a19b94f3f8b0bca12ec49b
|b 10
|u dkfz
700 1 _ |a Utikal, Jochen
|0 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
|b 11
|u dkfz
700 1 _ |a Altevogt, Peter
|0 P:(DE-He78)e6057131c71c90a6fcf61035f12b46c3
|b 12
|u dkfz
700 1 _ |a Umansky, Viktor
|0 P:(DE-He78)38be34240daf8b47325afc7910e77f7b
|b 13
|e Last author
|u dkfz
773 _ _ |a 10.1136/jitc-2022-005551
|g Vol. 10, no. 9, p. e005551 -
|0 PERI:(DE-600)2719863-7
|n 9
|p e005551
|t Journal for ImmunoTherapy of Cancer
|v 10
|y 2022
|x 2051-1426
909 C O |p VDB
|o oai:inrepo02.dkfz.de:181748
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)1784bfc87359b14c283e6b02cabca28d
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 2
|6 P:(DE-He78)d56d42ddfa25c8d79cba10aed608b0df
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 3
|6 P:(DE-He78)5f0b1c9863f44d0695555ee3c22b9758
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 4
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 5
|6 P:(DE-He78)0a2b5a217e49dccee55281ec2fb99f38
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)b3119317bcde901d53a7f3cea31994b5
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 8
|6 P:(DE-He78)8016386dca5752ba923e058df5966274
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 9
|6 P:(DE-He78)9f73dd6f3a8b9ba22a653f5d0257bd6f
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 10
|6 P:(DE-He78)70ce269695a19b94f3f8b0bca12ec49b
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 11
|6 P:(DE-He78)a229f7724466e7efadf4a1ace1ff8af3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 12
|6 P:(DE-He78)e6057131c71c90a6fcf61035f12b46c3
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)38be34240daf8b47325afc7910e77f7b
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-311
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Zellbiologie und Tumorbiologie
|x 0
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version)
|0 LIC:(DE-HGF)CCBYNCNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-01-28
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-01-28
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-01-28
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J IMMUNOTHER CANCER : 2021
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-01-14T19:11:13Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-01-14T19:11:13Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-01-14T19:11:13Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2022-11-08
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-08
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-08
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b J IMMUNOTHER CANCER : 2021
|d 2022-11-08
920 2 _ |0 I:(DE-He78)A370-20160331
|k A370
|l KKE Dermatoonkologie
|x 0
920 1 _ |0 I:(DE-He78)A370-20160331
|k A370
|l KKE Dermatoonkologie
|x 0
920 1 _ |0 I:(DE-He78)C060-20160331
|k C060
|l C060 Biostatistik
|x 1
920 0 _ |0 I:(DE-He78)A370-20160331
|k A370
|l KKE Dermatoonkologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)A370-20160331
980 _ _ |a I:(DE-He78)C060-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21